Browse press releases
The newest releases come first, each with its full text here and a link to its original. Try the filters to narrow them down.
- Quince Therapeutics to Host Virtual KOL Event to Discuss the Current Treatment Landscape for PH-ILD and BOS and the Role for LAM-001 as a Potential Therapeutic Option on September 28, 2026Quince Therapeutics, Inc. (Nasdaq: QNCX), a clinical stage biopharmaceutical company focused on the development of novel, disease modifying therapies for serious, underserved diseases, today announced that it will host a virtual key opinion leader (KOL) event on Monday, September 28, 2026 from 12:30-2:00 PM ET. The event will feature PH-ILD experts Aaron B. Waxman, MD, PhD (Brigham and Women's Hospital) and Paul Yu, MD, PhD (Massachusetts General Hospital), as well as BOS expert Steven Hays, MD (UCSF Health) to discuss the current treatment landscape and unmet need for PH-ILD and BOS as well as the role for LAM-001 as a potential new therapeutic option. To register, click here.
- Recludix Pharma, Inc.Recludix Pharma to Present at the Stifel 2026 Virtual Immunology and Inflammation ForumRecludix Pharma, a clinical-stage company leading the discovery and development of inhibitors of challenging targets for inflammatory disease, today announced that Nancy Whiting, Pharm.D., chief executive officer, and Ajay Nirula, M.D., Ph.D., president and head of research and development, will present an overview of the company at the Stifel 2026 Virtual Immunology and Inflammation Forum. The company’s presentation will be on Thursday, September 24, 2026, at 3:30 p.m. Eastern Time.
- Hemab Therapeutics Announces First Participant Dosed in Phase 1 Clinical Trial of HMB-003, an Investigational Therapy for the Management of Heavy Menstrual BleedingHeavy menstrual bleeding is reported in approximately 1 in 3 reproductive-aged women, according to the American College of Obstetricians and Gynecologists, with approximately 23 million seeking care from a healthcare professional in the U.S. last year.
- Rakovina Therapeutics Announces Appointment of New Scientific Advisory Board MemberYale physician-scientist and biotech entrepreneur Dr. Ranjit Bindra brings deep expertise in DNA repair, synthetic lethality and brain tumor therapeutics
- Avantor and Financial NewsAvantor Expands RIM Single-Use Portfolio Across APACCompanies: AvantorSINGAPORE, Sept 17, 2026 - Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, is expanding availability of its RIM® single-use portfolio of bioprocessing solutions across Asia Pacific (APAC). This gives biopharmaceutical manufacturers greater access to local solutions designed to support continuity of supply, efficient operations, and specific requirements that they need. RIM's proprietary technology provides single-use bioprocess customers with differentiated product offerings. Gladys Wang, Vice President, Bioprocessing, Asia Pacific, Avantor, says: “Customers across APAC are looking for reliable single-use solutions that can support their manufacturing needs close to home. By expanding the availability of RIM solutions across the region, we are helping customers access customizable products backed by the responsiveness of regional manufacturing and the consistency of Avantor’s global quality systems.” RIM provides reliable single-use bioprocessing solutions to enable biomanufacturers scale with confidence. The RIM portfolio includes single-use consumables including bioprocessing bags, assemblies and tubing and components, as well as mixing and storage hardware, to support a range of bioprocessing applications. RIM single-use consumables are manufactured at Avantor’s Changzhou, China, facility, the company’s first single-use production plant in APAC. The 2,600-square-meter facility has more than 20 years of single-use design and manufacturing experience, is certified to ISO 9001:2015 and operates in compliance with Good Manufacturing Practice (GMP) principles. RIM provides reliable single-use bioprocessing solutions designed to support unique process requirements, helping biomanufacturers scale with confidence. With in-region manufacturing and local component supply chains, RIM enables Avantor to support APAC customers with a more responsive supply model and right-fit solutions for their workflows. RIM products are available exclusively to customers in APAC. For more information about RIM single-use consumables, visit corporate.avantorsciences.com/sg/en/brands/rim About Avantor® Avantor® is a leading life science tools company and global provider of mission-critical products and services to the life sciences and advanced technology industries. We work side-by-side with customers at every step of the scientific journey to enable breakthroughs in medicine, healthcare, and technology. Our portfolio is used in virtually every stage of the most important research, development and production activities at more than 300,000 customer locations in 180 countries. For more information, find us on LinkedIn, X (Twitter) and Facebook. Regional Media Contact Swati Chhabra Manager, Corporate Communications, AMEA Avantor 91-9958-404-334 [email protected] Global Media Contact Valerie Collado Director, Community Impact and Communications Avantor [email protected] SOURCE: Avantor and Financial News
- Piramal Pharma Solutions treibt Nachhaltigkeitsbemühungen mit Bau einer Solaranlage am Standort Morpeth im Vereinigten Königreich voranPiramal Pharma Solutions errichtet an seinem integrierten Standort für Wirkstoffe und Fertigarzneimittel in Morpeth, im Vereinigten Königreich, eine Freiflächen-Solaranlage (4,3 MWp). Die neue Anlage wird den Standort über eine Behind-the-Meter-Konfiguration direkt mit erneuerbarer...
- MindMaze Therapeutics Holding SAMindMaze Therapeutics Announces MindMotion Lite to Expand Home-Based NeurorehabilitationExpected by year-end 2026, the new solution brings the full range of MindMotion neurotherapeutic activities to a tablet-based format designed for easier deployment at home — MindMaze Therapeutics (SIX: MMTX), a global leader in scalable precision...
- Robbins Geller Rudman & Dowd LLPSEPTEMBER 28, 2026 CAPR INVESTOR DEADLINE: Capricor Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action LawsuitThe law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Capricor Therapeutics, Inc. (NASDAQ: CAPR) securities between December 17, 2025 and July 26, 2026, both dates inclusive (the "Class Period"), have until...
- THE ROSEN LAW FIRM, P. A.SPRY Deadline: SPRY Investors Have Opportunity to Lead ARS Pharmaceuticals, Inc. Securities Fraud LawsuitRosen Law Firm, a global investor rights law firm, reminds purchasers of securities of ARS Pharmaceuticals, Inc. (NASDAQ: SPRY) between March 9, 2026 and June 24, 2026, inclusive (the "Class Period"), of the important October 5, 2026 lead plaintiff...
- THE ROSEN LAW FIRM, P. A.AARD Investors Have Opportunity to Lead Aardvark Therapeutics, Inc. Securities Fraud LawsuitRosen Law Firm, a global investor rights law firm, reminds purchasers of Aardvark Therapeutics, Inc. (NASDAQ: AARD): (i) common stock pursuant and/or traceable to the registration statement and prospectus (collectively, the "Registration...
- Avantor and Financial NewsAvantor Expands RIM Single-Use Portfolio Across APACCompanies: AvantorSINGAPORE, Sept 17, 2026 - Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, is expanding availability of its RIM® single-use portfolio of bioprocessing solutions across Asia Pacific (APAC). This gives biopharmaceutical manufacturers greater access to local solutions designed to support continuity of supply, efficient operations, and specific requirements that they need. RIM's proprietary technology provides single-use bioprocess customers with differentiated product offerings. Gladys Wang, Vice President, Bioprocessing, Asia Pacific, Avantor, says: “Customers across APAC are looking for reliable single-use solutions that can support their manufacturing needs close to home. By expanding the availability of RIM solutions across the region, we are helping customers access customizable products backed by the responsiveness of regional manufacturing and the consistency of Avantor’s global quality systems.” RIM provides reliable single-use bioprocessing solutions to enable biomanufacturers scale with confidence. The RIM portfolio includes single-use consumables including bioprocessing bags, assemblies and tubing and components, as well as mixing and storage hardware, to support a range of bioprocessing applications. RIM single-use consumables are manufactured at Avantor’s Changzhou, China, facility, the company’s first single-use production plant in APAC. The 2,600-square-meter facility has more than 20 years of single-use design and manufacturing experience, is certified to ISO 9001:2015 and operates in compliance with Good Manufacturing Practice (GMP) principles. RIM provides reliable single-use bioprocessing solutions designed to support unique process requirements, helping biomanufacturers scale with confidence. With in-region manufacturing and local component supply chains, RIM enables Avantor to support APAC customers with a more responsive supply model and right-fit solutions for their workflows. RIM products are available exclusively to customers in APAC. For more information about RIM single-use consumables, visit corporate.avantorsciences.com/sg/en/brands/rim About Avantor® Avantor® is a leading life science tools company and global provider of mission-critical products and services to the life sciences and advanced technology industries. We work side-by-side with customers at every step of the scientific journey to enable breakthroughs in medicine, healthcare, and technology. Our portfolio is used in virtually every stage of the most important research, development and production activities at more than 300,000 customer locations in 180 countries. For more information, find us on LinkedIn, X (Twitter) and Facebook. Regional Media Contact Swati Chhabra Manager, Corporate Communications, AMEA Avantor 91-9958-404-334 [email protected] Global Media Contact Valerie Collado Director, Community Impact and Communications Avantor [email protected] SOURCE: Avantor and Financial News
- Robinson Pharma, Inc.Robinson Pharma, Inc. Receives "Above and Beyond" Supplier Award from Bausch + Lomb for September 2026Robinson Pharma, Inc. (RPI), a premier full-service contract manufacturer of dietary supplements and nutraceuticals, is proud to announce that it has been honored by Bausch + Lomb with the "Above and Beyond" Supplier Award for the month of...